Profound Medical Corp. (PRN.TO) TSX

Currency In CAD

AD

Valuation

Market Cap237.11M
Enterprise Value182.2M
P/E Ratio-6.98
PEG Ratio-0.17
Price/Sales Ratio12.97
Price/Book Ratio4.95
Enterprise/Revenue11.34
Enterprise/EBITDA-6.43

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-1.71
Operating Margin-1.84
AD

Management Effectiveness

Return On Assets-0.52
Return On Equity-0.62

Income Statement

Revenue16.38M
Revenue/Share0.52
Gross Profit11.59M
EBITDA-41.41M
Net Income-43.32M
Diluted EPS-1.43

Balance Sheet

Total Cash38.21M
Total Cash/Share1.05
Total Debt7.37M
Total Debt/Equity0.15
Current Ratio6.46
Book Value Per Share1.37

Price History

52-Week Change42.94
52-Week High12.4
52-Week Low5.23
Moving Average 50 Days9.85
Moving Average 200 Days9.51

Statistics

Average Volume12,990
Shares Outstanding36.34M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateOctober 16, 2019
AD